170 related articles for article (PubMed ID: 9363174)
41. Fatal interstitial lung disease associated with Crizotinib pathologically confirmed by percutaneous lung biopsy in a patient with ROS1-rearranged advanced non-small-cell lung cancer: a case report.
Wu S; Liu K; Ren F; Zheng D; Pan D
BMC Pulm Med; 2018 Jul; 18(1):121. PubMed ID: 30029601
[TBL] [Abstract][Full Text] [Related]
42. Drug-induced interstitial pneumonitis due to low-dose lenalidomide.
Kunimasa K; Ueda T; Arita M; Maeda T; Hotta M; Ishida T
Intern Med; 2012; 51(9):1081-5. PubMed ID: 22576392
[TBL] [Abstract][Full Text] [Related]
43. Nivolumab-induced interstitial lung disease analysis of two phase II studies patients with recurrent or advanced non-small-cell lung cancer.
Kato T; Masuda N; Nakanishi Y; Takahashi M; Hida T; Sakai H; Atagi S; Fujita S; Tanaka H; Takeda K; Satouchi M; Namba Y; Tamura T
Lung Cancer; 2017 Feb; 104():111-118. PubMed ID: 28212992
[TBL] [Abstract][Full Text] [Related]
44. [Expert consensus on the diagnosis and treatment of anticancer drug-induced interstitial lung disease].
Anticancer Drug-induced Interstitial Lung Disease Management Group
Zhonghua Zhong Liu Za Zhi; 2022 Jul; 44(7):693-702. PubMed ID: 35880334
[TBL] [Abstract][Full Text] [Related]
45. Amiodarone lung toxicity in a cardiac transplant candidate initially diagnosed by fine-needle aspiration: cytologic, histologic, and electronmicroscopic findings.
Omeroglu G; Kalugina Y; Ersahin C; Wojcik EM
Diagn Cytopathol; 2006 May; 34(5):351-4. PubMed ID: 16604561
[TBL] [Abstract][Full Text] [Related]
46. [Major drug-induced lung diseases: Adverse effects of antibacterial agents].
Chida K
Nihon Naika Gakkai Zasshi; 2007 Jun; 96(6):1143-8. PubMed ID: 17607990
[No Abstract] [Full Text] [Related]
47. [Interstitial pneumonitis].
Hirai F; Toyokawa G; Ohba T; Kitajima H; Yamaguchi M; Maruyama R; Hamatake M; Seto T; Sugio K; Ichinose Y
Gan To Kagaku Ryoho; 2011 Nov; 38(11):1782-4. PubMed ID: 22083185
[TBL] [Abstract][Full Text] [Related]
48. Diffuse alveolar damage in a patient receiving dronedarone.
Stack S; Nguyen DV; Casto A; Ahuja N
Chest; 2015 Apr; 147(4):e131-e133. PubMed ID: 25846536
[TBL] [Abstract][Full Text] [Related]
49. [Drug-induced interstitial lung diseases: often forgotten].
Poschenrieder F; Stroszczynski C; Hamer OW
Radiologe; 2014 Dec; 54(12):1180-8. PubMed ID: 25446693
[TBL] [Abstract][Full Text] [Related]
50. [Analysis of Risk Factors for Side Effects and the Establishment of Supportive Therapy during Cancer Chemotherapy].
Sakurada T
Yakugaku Zasshi; 2018; 138(11):1363-1370. PubMed ID: 30381644
[TBL] [Abstract][Full Text] [Related]
51. [Adverse effects of drugs on the hearing organ].
Mees K
Laryngol Rhinol Otol (Stuttg); 1986 Jul; 65(7):363-70. PubMed ID: 3528724
[TBL] [Abstract][Full Text] [Related]
52. Severe interstitial pneumonia induced by paclitaxel in a patient with adenocarcinoma of the lung.
Suzaki N; Hiraki A; Takigawa N; Ueoka H; Tanimoto Y; Kozuki T; Tabata M; Kanehiro A; Kiura K; Tanimoto M
Acta Med Okayama; 2006 Oct; 60(5):295-8. PubMed ID: 17072376
[TBL] [Abstract][Full Text] [Related]
53. Respiratory disease and respiratory physiology: putting lung function into perspective interstitial lung disease.
Berend N
Respirology; 2014 Oct; 19(7):952-9. PubMed ID: 25039623
[TBL] [Abstract][Full Text] [Related]
54. [Major drug-induced lung diseases: adverse effects of anti-neoplastic agents in general].
Nakanishi Y; Harada T; Takayama K
Nihon Naika Gakkai Zasshi; 2007 Jun; 96(6):1123-8. PubMed ID: 17607987
[No Abstract] [Full Text] [Related]
55. Flecainide-associated pneumonitis with acute respiratory failure in a patient with the LEOPARD syndrome.
Robain A; Perchet H; Fuhrman C
Acta Cardiol; 2000 Feb; 55(1):45-7. PubMed ID: 10707759
[TBL] [Abstract][Full Text] [Related]
56. Drug-induced interstitial lung disease: mechanisms and best diagnostic approaches.
Matsuno O
Respir Res; 2012 May; 13(1):39. PubMed ID: 22651223
[TBL] [Abstract][Full Text] [Related]
57. Erlotinib-induced acute interstitial lung disease associated with extreme elevation of the plasma concentration in an elderly non-small-cell lung cancer patient.
Tsubata Y; Hamada A; Sutani A; Isobe T
J Cancer Res Ther; 2012; 8(1):154-6. PubMed ID: 22531540
[TBL] [Abstract][Full Text] [Related]
58. Downstaging of Non-Small-Cell Lung Cancer Through Identification of Reversible Drug Toxicity.
Browning ET; Huckleberry JM; Barrow WB; Restauri NL; Kemme DJ; Cool CD; Weyant MJ; Franklin WA; Camidge DR
J Clin Oncol; 2016 Jan; 34(2):e6-8. PubMed ID: 24799494
[No Abstract] [Full Text] [Related]
59. [Characteristics of and risk factors for interstitial pneumonia due to TS-1(R) capsule administration-case reviews from a drug use results survey on Non-Small Cell Lung cancer patients and spontaneous reports].
Ito K; Jin Z
Gan To Kagaku Ryoho; 2015 May; 42(5):595-603. PubMed ID: 25981654
[TBL] [Abstract][Full Text] [Related]
60. [Strategy of therapy for interstitial lung disease due to chemotherapeutic drugs or radiation].
Ishioka S
Gan To Kagaku Ryoho; 1997 Oct; 24 Suppl 3():432-8. PubMed ID: 9369919
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
